LINC01524

Across TCGA pan-cancer cohorts, LINC01524 RNA is linked to patient survival in 22 of 34 cancer types, making it the most broadly survival-associated LINC01524 data layer.

The strongest signal is observed in ovarian serous cystadenocarcinoma (OV), where higher LINC01524 RNA is associated with worse overall survival. In most high-consensus cancer types, elevated LINC01524 expression acts as an unfavorable survival marker, although some lineages such as ESCA and PRAD show a favorable association.

OV, PAAD, and LUAD are the cancer types where LINC01524 RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
OV	OS	Median	All	0.796	0.878	<.001	56	view →
PAAD	OS	Median	II,III,IV	0.327	0.417	.010	50	view →
LUAD	DFS	Quartile	All	0.173	0.460	.001	41	view →
KIRC	DFS	Tertile	All	0.558	0.709	.003	38	view →
MESO	OS	Tertile	All	0.405	0.612	.006	31	view →
ESCA	DFS	Median	II,III,IV	1.000	0.399	.013	31	view →
KICH	OS	Tertile	III,IV	0.178	0.847	<.001	24	view →
UCEC	DFS	Tertile	All	0.592	0.656	.007	22	view →
DLBC	DFS	Median	III,IV	0.196	0.862	.008	21	view →
THCA	OS	Tertile	IV	0.783	1.000	<.001	15	view →
PRAD	DFS	Median	All	0.834	0.750	.007	14	view →
UCS	DFS	Quartile	II,III,IV	0.462	0.146	.020	12	view →

Pink = unfavorable, green = favorable. Showing the 12 strongest of 22 lineages.

LINC01524–OV (OS)

Open the OV breakdown →